Similar articles for PMID: 29903931

Year	Number of Results
1977	1
1978	1
1979	2
1980	1
1981	1
1982	1
1984	1
1985	1
1988	1
1990	1
1993	1
1995	1
1997	1
1998	3
2000	1
2001	1
2004	3
2007	2
2011	2
2012	3
2013	5
2014	3
2015	6
2016	9
2017	10
2018	5
2019	1
2024	0

1

Heterogeneity in Metastatic Breast Cancer ¹⁸F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?

Kurland BF, Oesterreich S. Kurland BF, et al. J Nucl Med. 2018 Aug;59(8):1210-1211. doi: 10.2967/jnumed.118.214304. Epub 2018 Jun 14. J Nucl Med. 2018. PMID: 29903931 Free PMC article. No abstract available.

2

Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?

Yang Z, Sun Y, Zhang Y, Xue J, Wang M, Shi W, Zhu B, Hu S, Yao Z, Pan H, Zhang Y. Yang Z, et al. Clin Breast Cancer. 2013 Oct;13(5):359-63. doi: 10.1016/j.clbc.2013.02.012. Epub 2013 Jun 17. Clin Breast Cancer. 2013. PMID: 23787040

3

The Assessment of Estrogen Receptor Status and Its Intratumoral Heterogeneity in Patients With Breast Cancer by Using 18F-Fluoroestradiol PET/CT.

Yang Z, Sun Y, Xu X, Zhang Y, Zhang J, Xue J, Wang M, Yuan H, Hu S, Shi W, Zhu B, Zhang Y. Yang Z, et al. Clin Nucl Med. 2017 Jun;42(6):421-427. doi: 10.1097/RLU.0000000000001587. Clin Nucl Med. 2017. PMID: 28221191

4

Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.

Venema CM, Mammatas LH, Schröder CP, van Kruchten M, Apollonio G, Glaudemans AWJM, Bongaerts AHH, Hoekstra OS, Verheul HMW, Boven E, van der Vegt B, de Vries EFJ, de Vries EGE, Boellaard R, Menke van der Houven van Oordt CW, Hospers GAP. Venema CM, et al. J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14. J Nucl Med. 2017. PMID: 28912144 Free article. Clinical Trial.

5

Breast cancer: PET imaging of estrogen receptors.

Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, Katzenellenbogen JA. Mintun MA, et al. Radiology. 1988 Oct;169(1):45-8. doi: 10.1148/radiology.169.1.3262228. Radiology. 1988. PMID: 3262228

6

18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.

Liao GJ, Clark AS, Schubert EK, Mankoff DA. Liao GJ, et al. J Nucl Med. 2016 Aug;57(8):1269-75. doi: 10.2967/jnumed.116.175596. Epub 2016 Jun 15. J Nucl Med. 2016. PMID: 27307345 Free article. Review.

7

A Randomized Feasibility Study of ¹⁸F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.

Chae SY, Kim SB, Ahn SH, Kim HO, Yoon DH, Ahn JH, Jung KH, Han S, Oh SJ, Lee SJ, Kim HJ, Son BH, Gong G, Lee HS, Moon DH. Chae SY, et al. J Nucl Med. 2017 Apr;58(4):563-568. doi: 10.2967/jnumed.116.178368. Epub 2016 Sep 29. J Nucl Med. 2017. PMID: 27688475 Free article. Clinical Trial.

8

Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.

Kumar P, Mercer J, Doerkson C, Tonkin K, McEwan AJ. Kumar P, et al. J Pharm Pharm Sci. 2007;10(2):256s-265s. J Pharm Pharm Sci. 2007. PMID: 17718929 Free article. Clinical Trial.

9

Automated SPE-based synthesis of 16α-[¹⁸F]fluoroestradiol without HPLC purification step.

Fedorova O, Nikolaeva V, Krasikova R. Fedorova O, et al. Appl Radiat Isot. 2018 Nov;141:57-63. doi: 10.1016/j.apradiso.2018.08.007. Epub 2018 Aug 10. Appl Radiat Isot. 2018. PMID: 30176563

10

¹⁸F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.

Groheux D. Groheux D. J Nucl Med. 2017 Apr;58(4):683. doi: 10.2967/jnumed.116.185579. Epub 2016 Nov 10. J Nucl Med. 2017. PMID: 28373394 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year